Point-of-care molecular diagnostics instrumentation
Biocartis is a commercial stage company which develops novel molecular diagnostics. The proprietary Idylla™ platform is a fully automated, real-time system which provides accurate, highly-reliable RNA and protein expression information from any biological sample, thus improving diagnosis and facilitating personalised therapy at the point of care.
CEO Rudi Pauwels
Advent Contact Raj Parekh